These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12419502)

  • 61. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
    Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
    J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis.
    Siciliano G; Piazza S; Carlesi C; Del Corona A; Franzini M; Pompella A; Malvaldi G; Mancuso M; Paolicchi A; Murri L
    J Neurol; 2007 May; 254(5):575-80. PubMed ID: 17426914
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease.
    Tateno F; Sakakibara R; Kawai T; Kishi M; Murano T
    Alzheimer Dis Assoc Disord; 2012; 26(3):213-6. PubMed ID: 22037599
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases.
    Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP
    J Neurochem; 1994 Sep; 63(3):1178-80. PubMed ID: 8051562
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
    Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    Lemstra AW; de Beer MH; Teunissen CE; Schreuder C; Scheltens P; van der Flier WM; Sikkes SA
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):113-118. PubMed ID: 27794030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma kallikrein-bradykinin pathway promotes circulatory nitric oxide metabolite availability during hypoxia.
    Padhy G; Gangwar A; Sharma M; Himashree G; Singh K; Bhaumik G; Bhargava K; Sethy NK
    Nitric Oxide; 2016 May; 55-56():36-44. PubMed ID: 26952290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study.
    Ramirez J; Garnica R; Boll MC; Montes S; Rios C
    Schizophr Res; 2004 Jun; 68(2-3):357-61. PubMed ID: 15099617
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.
    Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M
    J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
    Wennström M; Hall S; Nägga K; Londos E; Minthon L; Hansson O
    Alzheimers Res Ther; 2015 Oct; 7(1):63. PubMed ID: 26434635
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage.
    Suzuki Y; Osuka K; Noda A; Tanazawa T; Takayasu M; Shibuya M; Yoshida J
    Neurosurgery; 1997 Oct; 41(4):807-11; discussion 811-2. PubMed ID: 9316041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
    Schultz K; Nilsson K; Nielsen JE; Lindquist SG; Hjermind LE; Andersen BB; Wallin A; Nilsson C; Petersén A
    Eur J Neurol; 2010 Mar; 17(3):456-60. PubMed ID: 19922456
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protection against hepatic ischemia/reperfusion injury by exogenous L-arginine.
    Shiraishi M; Kusano T; Aihara T; Ikeda Y; Koyama Y; Muto Y
    Transplant Proc; 1996 Jun; 28(3):1887-8. PubMed ID: 8658931
    [No Abstract]   [Full Text] [Related]  

  • 77. [Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies].
    Kasuga K; Ikeuchi T
    Brain Nerve; 2012 May; 64(5):505-13. PubMed ID: 22570064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nitrite and nitrate levels in cerebrospinal fluid of normal subjects.
    Zecca L; Rosati M; Renella R; Galimberti M; Ambrosini A; Fariello RG
    J Neural Transm (Vienna); 1998; 105(6-7):627-33. PubMed ID: 9826107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum?
    Gore RL; Vardy ER; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):50-9. PubMed ID: 24860139
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction.
    Giovannoni G; Miller RF; Heales SJ; Land JM; Harrison MJ; Thompson EJ
    J Neurol Sci; 1998; 156(1):53-8. PubMed ID: 9559987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.